CD8+CD20+ Cytotoxic T Lymphocytes Exhibit Augmented Degranulation and Pro-inflammatory Potential in Multiple Sclerosis

preprint OA: closed
Full text JSON View at publisher

Abstract

ABSTRACT The effectiveness of CD20-targeting therapies in multiple sclerosis (MS) underscores the role of B cells in the disease, yet the limited success of other B cell-specific treatments suggests additional mechanisms at play. Intriguingly, CD20 is also expressed on a subset of highly active memory T cells, particularly cytotoxic CD8+ T lymphocytes (CTLs). This study investigated the functional characteristics of CD8+CD20+ CTLs in MS. We observed a significant increase in CD8+CD20+ CTL prevalence in MS patients, with enhanced infiltration into the cerebrospinal fluid. Consistent with prior reports, these cells exhibited heightened proliferation and production of IFN-γ, TNF-α, and GM-CSF. Notably, we demonstrate for the first time that CD8+CD20+ CTLs display escalated degranulation and produce significantly higher levels of Granzyme B, Perforin, and Granzyme K compared to their CD20-counterparts, with further augmentation in pwMS compared to healthy controls. These findings suggest that in MS, CD8+CD20+ CTLs are actively recruited to the CNS, exhibiting enhanced cytotoxicity and a potent pro-inflammatory profile, particularly through elevated Granzyme K production, contributing significantly to the chronic inflammatory milieu and immunopathogenesis of MS.
Full text 1,355 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT The effectiveness of CD20-targeting therapies in multiple sclerosis (MS) underscores the role of B cells in the disease, yet the limited success of other B cell-specific treatments suggests additional mechanisms at play. Intriguingly, CD20 is also expressed on a subset of highly active memory T cells, particularly cytotoxic CD8+ T lymphocytes (CTLs). This study investigated the functional characteristics of CD8+CD20+ CTLs in MS. We observed a significant increase in CD8+CD20+ CTL prevalence in MS patients, with enhanced infiltration into the cerebrospinal fluid. Consistent with prior reports, these cells exhibited heightened proliferation and production of IFN-γ, TNF-α, and GM-CSF. Notably, we demonstrate for the first time that CD8+CD20+ CTLs display escalated degranulation and produce significantly higher levels of Granzyme B, Perforin, and Granzyme K compared to their CD20-counterparts, with further augmentation in pwMS compared to healthy controls. These findings suggest that in MS, CD8+CD20+ CTLs are actively recruited to the CNS, exhibiting enhanced cytotoxicity and a potent pro-inflammatory profile, particularly through elevated Granzyme K production, contributing significantly to the chronic inflammatory milieu and immunopathogenesis of MS. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00